Philippe Vergauwe

4.1k total citations · 1 hit paper
49 papers, 1.6k citations indexed

About

Philippe Vergauwe is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Philippe Vergauwe has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Surgery and 11 papers in Epidemiology. Recurrent topics in Philippe Vergauwe's work include Colorectal Cancer Treatments and Studies (14 papers), Inflammatory Bowel Disease (10 papers) and Microscopic Colitis (9 papers). Philippe Vergauwe is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Inflammatory Bowel Disease (10 papers) and Microscopic Colitis (9 papers). Philippe Vergauwe collaborates with scholars based in Belgium, United Kingdom and Netherlands. Philippe Vergauwe's co-authors include Geert D’Haens, Martine De Vos, Gert Van Assche, Filip Baert, Philip Caenepeel, Daniël W. Hommes, Séverine Vermeire, Paul Rutgeerts, Liesbeth Moortgat and Pieter Stokkers and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Annals of Oncology.

In The Last Decade

Philippe Vergauwe

48 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

2009 648 citations Filip Baert, Gert Van Assche et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Vergauwe Belgium	16	812	794	536	473	243	49	1.6k
Nicolas Williet France	22	1.3k 1.6×	1.1k 1.4×	585 1.1×	328 0.7×	185 0.8×	70	2.2k
Francesco Selvaggi Italy	27	735 0.9×	567 0.7×	1.2k 2.3×	641 1.4×	152 0.6×	110	2.4k
Frank Klebl Germany	25	563 0.7×	504 0.6×	573 1.1×	179 0.4×	201 0.8×	80	1.5k
Sally G. Mitton United Kingdom	15	988 1.2×	666 0.8×	505 0.9×	183 0.4×	79 0.3×	26	1.7k
Tae Oh Kim South Korea	22	274 0.3×	282 0.4×	568 1.1×	448 0.9×	464 1.9×	133	1.5k
Ole Høie Norway	21	1.9k 2.4×	1.7k 2.2×	1.0k 1.9×	480 1.0×	380 1.6×	36	2.7k
Alessandra Zilli Italy	21	521 0.6×	638 0.8×	568 1.1×	274 0.6×	114 0.5×	96	1.4k
Pietro Renzulli Switzerland	21	318 0.4×	274 0.3×	1.1k 2.1×	395 0.8×	205 0.8×	56	1.6k
J Y Mary France	17	1.4k 1.8×	1.1k 1.4×	734 1.4×	184 0.4×	73 0.3×	31	2.1k
Jean‐François Rahier Belgium	21	741 0.9×	581 0.7×	344 0.6×	607 1.3×	102 0.4×	60	2.0k

Countries citing papers authored by Philippe Vergauwe

Since Specialization

Citations

This map shows the geographic impact of Philippe Vergauwe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Vergauwe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Vergauwe more than expected).

Fields of papers citing papers by Philippe Vergauwe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Vergauwe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Vergauwe. The network helps show where Philippe Vergauwe may publish in the future.

Co-authorship network of co-authors of Philippe Vergauwe

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Vergauwe. A scholar is included among the top collaborators of Philippe Vergauwe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Vergauwe. Philippe Vergauwe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sclafani, Francesco, Giacomo Bregni, Francesco Puleo, et al.. (2024). LBA2 Interim efficacy analysis of REGINA, a phase II trial of neoadjuvant regorafenib (Rego), nivolumab (Nivo), and short-course radiotherapy (SCRT) in stage II-III rectal cancer (RC). Annals of Oncology. 35. S212–S213.

Baldin, Paméla, Javier Carrasco, Anne Jouret‐Mourin, et al.. (2022). Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial). Cancers. 14(5). 1183–1183. 2 indexed citations

Pottel, Hans, Koen Van Eygen, Sofie Derijcke, et al.. (2021). Acupuncture as a Complementary Therapy for Cancer Care: Acceptability and Preferences of Patients and Informal Caregivers. Journal of Acupuncture and Meridian Studies. 14(2). 67–74. 2 indexed citations

Truyens, Marie, et al.. (2020). Boerhaave's syndrome: successful conservative treatment in two patients.. Acta gastro-enterologica belgica. 83(4). 654–656. 1 indexed citations

Houte, Karen Van den, Florencia Carbone, Jolien Schol, et al.. (2020). Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care. Clinical Gastroenterology and Hepatology. 19(8). 1620–1626. 25 indexed citations

Vandijck, Dominique, Michelle Lycke, Philippe Vergauwe, et al.. (2019). An observational pilot study to evaluate the feasibility and quality of oncological home-hospitalization. European Journal of Oncology Nursing. 40. 44–52. 14 indexed citations

Rothé, Françoise, Marion Maetens, Ghizlane Rouas, et al.. (2019). CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial. BMC Cancer. 19(1). 304–304. 14 indexed citations

Lycke, Michelle, Lies Pottel, Hans Pottel, et al.. (2019). Underrepresentation of vulnerable older patients with cancer in phase II and III oncology registration trials: A case-control study. Journal of Geriatric Oncology. 11(2). 320–326. 15 indexed citations

Hoekman, Daniël R., Filip J. Baert, Philip Caenepeel, et al.. (2018). Long-term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn’s Disease. Journal of Crohn s and Colitis. 12(5). 517–524. 30 indexed citations

10.

Decoster, Lore, Cindy Kenis, Marc De Man, et al.. (2017). Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS). Journal of Geriatric Oncology. 9(2). 93–101. 14 indexed citations

11.

Cutsem, Eric Van, Lore Decoster, Marc De Man, et al.. (2016). PD-030 Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's ≥70 years. Annals of Oncology. 27. ii113–ii113. 1 indexed citations

12.

Borbath, Ivan, Chris Verslype, Anne Demols, et al.. (2013). Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology. Annals of Oncology. 24(11). 2824–2829. 42 indexed citations

13.

Orlent, Hans, et al.. (2008). Retrieval of a migrated esophagojejunal stent by using the double-balloon enteroscope. Gastrointestinal Endoscopy. 67(7). 1198–1199. 2 indexed citations

14.

Köhne, C.-H., Jacques De Grève, J. T. Hartmann, et al.. (2007). Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. Annals of Oncology. 19(5). 920–926. 127 indexed citations

15.

Hommes, DW, Filip Baert, Gert Van Assche, et al.. (2006). The ideal management of Crohn's disease: Top down versus step up strategies, a randomized controlled trial. Ghent University Academic Bibliography (Ghent University). 29 indexed citations

16.

Grève, Jacques De, Julia Hartmann, Philippe Vergauwe, et al.. (2006). Capecitabine plus irinotecan versus 5-FU/FA/irinotecan ± celecoxib in first line treatment of metastatic colorectal cancer (CRC). Long-term results of the prospective multicenter EORTC phase III study 40015. Journal of Clinical Oncology. 24(18_suppl). 3577–3577. 25 indexed citations

17.

Hommes, DW, Filip Baert, Gert Van Assche, et al.. (2005). A randomized controlled trial evaluating the ideal medical management for Crohn's disease (CD): Top-down versus step-up strategies. Ghent University Academic Bibliography (Ghent University). 24 indexed citations

18.

Vergauwe, Philippe, et al.. (1990). Near fatal subacute thallium poisoning necessitating prolonged mechanical ventilation. The American Journal of Emergency Medicine. 8(6). 548–550. 10 indexed citations

19.

Tielemans, Christian, et al.. (1989). Deferoxamine Does Not Increase the Risk for Bacteremia in Hemodialysis Patients. The Nephron journals/Nephron journals. 53(3). 276–277. 9 indexed citations

20.

Verbanck, J., F. Van Aelst, L Rutgeerts, et al.. (1988). The impact of routine admission abdominal sonography on patient care. Journal of Clinical Ultrasound. 16(9). 651–654. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact